Zevra Therapeutics Inc. (NASDAQ: ZVRA)
$9.6400
+0.0550 ( -0.10% ) 264.2K
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Market Data
Open
$9.6400
Previous close
$9.5850
Volume
264.2K
Market cap
$519.62M
Day range
$9.4080 - $9.7750
52 week range
$4.2000 - $9.7750
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Nov 22, 2024 |
10-q | Quarterly Reports | 78 | Nov 13, 2024 |
8-k | 8K-related | 16 | Nov 12, 2024 |
4 | Insider transactions | 1 | Oct 16, 2024 |
8-k | 8K-related | 16 | Sep 20, 2024 |
10-q | Quarterly Reports | 79 | Aug 14, 2024 |
8-k | 8K-related | 16 | Aug 13, 2024 |
8-k | 8K-related | 17 | Aug 09, 2024 |
8-k | 8K-related | 13 | Aug 08, 2024 |
8-k | 8K-related | 16 | Aug 05, 2024 |